Cannabinoid News and Research

Latest Cannabinoid News and Research

Rimonabant shows mixed results for slowing progression of coronary disease

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.

2 Apr 2008

New brain cells implicated in machinery of cannabinoid signaling

The researchers said their findings could aid in development of treatments for cannabinoid drug abuse. Also, because so-called "endocannabinoids" produced by brain cells are involved in the neural machinery of pain perception and learning and memory, the findings could help in understanding those processes, said the researchers.

28 Mar 2008

New behavioral risk factors for head and neck cancers

Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.

12 Mar 2008

The potential for cannabinoids as medicines

Smokers trying to quit in the future could do it with the help of cannabis based medicines, according to research from The University of Nottingham.

10 Mar 2008

Cannabis-derived medicines may help Alzheimer's

Cannabis-derived medicines may one day be used in the treatment of Alzheimer's disease which affects 417,000 people in the UK.

10 Mar 2008

Rimonabant weight-loss drug might fight alcoholic fatty liver

The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.

6 Mar 2008

Nabilone marijuana-based drug reduces fibromyalgia pain

Patients with fibromyalgia treated with a synthetic form of marijuana, nabilone, showed significant reductions in pain and anxiety in a first-of-its-kind study, published in The Journal of Pain.

17 Feb 2008

Taranabant shows promise for weight loss in obese people

The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose weight, even at very low doses.

9 Jan 2008

Search for new uses for heroin and marijuana

The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.

1 Nov 2007

Synthetic form of THC is an effective anti-depressant at low doses

A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.

24 Oct 2007

The importance of the endocannabinoid-system

Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe.

15 Oct 2007

How does the opioid system work?

The opioid system controls pain, reward and addictive behaviors. Opioids exert their pharmacological actions through three opioid receptors, mu, delta and kappa whose genes have been cloned (Oprm, Oprd1 and Oprk1, respectively).

15 Oct 2007

How does THC work?

Marijuana and its main psychoactive component, THC, exert a plethora of behavioral and autonomic effects on humans and animals.

9 Oct 2007

Addiction to chocolate

Chocolate is the most widely and frequently craved food. People readily admit to being 'addicted to chocolate' or willingly label themselves as 'chocoholics'. A popular explanation for this is that chocolate contains mood-enhancing (psychoactive) ingredients that give it special appeal.

10 Sep 2007

Cannabis for allergic contact dermatitis

Administering a substance found in the cannabis plant can help the body's natural protective system alleviate an allergic skin disease (allergic contact dermatitis), an international group of researchers from Germany, Israel, Italy, Switzerland and the U.S. has found.

17 Aug 2007

Cannabis mouth spray eases pain of cancer patients

Canadian health authorities have given approval for a new cannabis-based painkiller for use with cancer patients.

8 Aug 2007

Ddiscovery of a novel molecular switch offers potential for epilepsy

The discovery of a novel molecular switch that powerfully modulates nerve cell activity offers the potential for new mood disorder and epilepsy treatments, University of California, Irvine researchers report.

6 Aug 2007

Delta-9-tetrahydrocannabinol opens door for virus that causes Kaposi's sarcoma

The major active component of marijuana could enhance the ability of the virus that causes Kaposi's sarcoma to infect cells and multiply, according to a team of researchers at Harvard Medical School.

2 Aug 2007

Quitting smoking with rimonabant

Using selective cannabinoid 1 (CB1) receptor antagonists such as rimonabant at a dose of 20 mg per day can help people quit smoking, can help them to remain abstinent, and can help prevent the weight gain that so often accompanies attempts at stopping smoking.

18 Jul 2007

Rimonabant may prevent and treat obesity-related liver disease

A new study on the effect of the anti-obesity drug rimonabant on liver function in obese rats found that it reduced markers of liver damage, decreased levels of pro-inflammatory proteins, and improved lipid profiles.

4 Jul 2007